Prostate-cancer mortality at 11 years of follow-up
FH Schröder, J Hugosson, MJ Roobol… - … England Journal of …, 2012 - Mass Medical Soc
Background Several trials evaluating the effect of prostate-specific antigen (PSA) testing on
prostate-cancer mortality have shown conflicting results. We updated prostate-cancer …
prostate-cancer mortality have shown conflicting results. We updated prostate-cancer …
Screening and prostate-cancer mortality in a randomized European study
FH Schröder, J Hugosson, MJ Roobol… - New England journal …, 2009 - Mass Medical Soc
Background The European Randomized Study of Screening for Prostate Cancer was
initiated in the early 1990s to evaluate the effect of screening with prostate-specific–antigen …
initiated in the early 1990s to evaluate the effect of screening with prostate-specific–antigen …
Prostate-specific antigen screening and 15-year prostate cancer mortality: a secondary analysis of the CAP randomized clinical trial
Importance The Cluster Randomized Trial of PSA Testing for Prostate Cancer (CAP)
reported no effect of prostate-specific antigen (PSA) screening on prostate cancer mortality …
reported no effect of prostate-specific antigen (PSA) screening on prostate cancer mortality …
A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer
J Hugosson, MJ Roobol, M Månsson, TLJ Tammela… - European urology, 2019 - Elsevier
Abstract Background The European Randomized study of Screening for Prostate Cancer
(ERSPC) has previously demonstrated that prostate-specific antigen (PSA) screening …
(ERSPC) has previously demonstrated that prostate-specific antigen (PSA) screening …
Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence
JH Hayes, MJ Barry - Jama, 2014 - jamanetwork.com
Importance Prostate cancer screening with the prostate-specific antigen (PSA) test remains
controversial. Objective To review evidence from randomized trials and related modeling …
controversial. Objective To review evidence from randomized trials and related modeling …
Prostate cancer: screening and early detection
MS Cookson - Cancer Control, 2001 - journals.sagepub.com
Background Despite more than a decade of prostate-specific antigen (PSA)-based
screening, the proven impact of screening on mortality due to prostate cancer continues to …
screening, the proven impact of screening on mortality due to prostate cancer continues to …
Mortality results from a randomized prostate-cancer screening trial
GL Andriole, ED Crawford, RL Grubb III… - New England journal …, 2009 - Mass Medical Soc
Background The effect of screening with prostate-specific–antigen (PSA) testing and digital
rectal examination on the rate of death from prostate cancer is unknown. This is the first …
rectal examination on the rate of death from prostate cancer is unknown. This is the first …
Prostate cancer mortality in the Finnish randomized screening trial
TP Kilpeläinen, TL Tammela, N Malila… - Journal of the …, 2013 - academic.oup.com
Background Prostate cancer (PC) screening with prostate-specific antigen (PSA) has been
shown to decrease PC mortality by the European Randomized Study of Screening for …
shown to decrease PC mortality by the European Randomized Study of Screening for …
Screening for prostate cancer: results of the Rotterdam section of the European randomized study of screening for prostate cancer
MJ Roobol, R Kranse, CH Bangma, AG van Leenders… - European urology, 2013 - Elsevier
Background Evidence from randomized trials on the effects of screening for prostate cancer
(PCa) on disease-specific mortality accumulates slowly with increasing follow-up. Objective …
(PCa) on disease-specific mortality accumulates slowly with increasing follow-up. Objective …
Effect of a low-intensity PSA-based screening intervention on prostate cancer mortality: the CAP randomized clinical trial
Importance Prostate cancer screening remains controversial because potential mortality or
quality-of-life benefits may be outweighed by harms from overdetection and overtreatment …
quality-of-life benefits may be outweighed by harms from overdetection and overtreatment …